Slashdot Mirror


A Protein That Terminates 70% Of Common Cancers

Orne writes "BBC News reports here that researchers at the Washington University School of Medicine in St Louis have located 'a protein CUGBP2 (that) interacted with the mRNA for Cox-2 in eight types of human cancer cells.' Cox-2 (which is already known to affect inflammation in arthritis sufferers) is involved in growing blood vessels to feed cancer cells, leading to their uncontrolled growth. Raising CUGBP2 to normal levels puts the cancer's 'death' cycle back on track."

16 of 48 comments (clear)

  1. in related news by pizza_milkshake · · Score: 3, Funny

    Microsoft claims Cox-2 has no effect on the GPL. Film at 11

  2. good, but... by C21 · · Score: 3, Interesting

    what are the side effects with flooding tissue with this protein?

    --
    this is not a sig.
    1. Re:good, but... by Simon+Field · · Score: 4, Informative


      Normal tissue already produces plenty of this protein.

      It has low levels in tumors, and raising the levels to 'normal' shrinks the tumors.

  3. More info here... by Simon+Field · · Score: 4, Informative


    See this article for a slightly more technical treatment of the item.

  4. Re:Thats great and all... by mrscott · · Score: 5, Insightful

    You're probably right, although I doubt it will be 20 years. But, if it upsets you that it won't be useful to today's cancer patients, maybe they should just stop their work and give up? After all, nothing good can come from research.

    Honestly, what is the deal with the extreme negativity and cynicism from the Slashdot crowd?

  5. Re:Thats great and all... by EggplantMan · · Score: 3, Funny

    Wouldn't you be cynical if you had never been laid and still live in your parents' basement?

    --

    ?-|||-----x<*))))><
  6. Any way to volunteer for tests? by Cyclone66 · · Score: 3, Interesting

    It's probably to early but anyone who knows people with inoperable cancer would probably love to try anything.. just the hope it would give them would make there last days/months/years of life more bareable.

  7. Too soon to tell, but... by geekwench · · Score: 3, Informative
    I'm in favor of anything that provides even a minor stepping stone toward a reasonably non-toxic cancer treatment. Chemotherapy is probably the most effective bullet in the current arsenal, but the damages that it causes to healthy calls can be permanent. Depending on the organ, and the severity, the cure has the potential to be not much of an improvement over the disease.

    None of the articles mentioned a timeline to human testing (at least not that I could find). I'm going to be watching this research closely. I've seen too many people succumb to their own bodies going haywire.

    --
    Doing my level best to piss off the religious right wing...
  8. Why isn't this front page?? by Anonymous Coward · · Score: 3, Insightful

    After some of the things that have made front page lately I'd think that a way to stabilize 70% of cancers would make it. It's no flying car, but hey, it's nice.

  9. UD.. by olman · · Score: 3, Interesting

    I wonder if all those UD packets I crunched had anything to contribute. Probably not.

  10. Interesting Statistics by Frodo.20 · · Score: 5, Informative

    The protein doesn't kill 70% of common cancers, it kills 70% of the cells of the 8 tumor types it was tested in.
    A) This means that 30% of the tumor survives the treatment. This is a good start for a treatment but alone it is not a cure as the remaining 30% will continue to grow and spread.
    B) There are many more types of tumor which it hasn't been tested in so this is not exactly the mythic magic bullett.

    In addition this has not been tested in a physiological situation. While it is a natural substance you can't just throw it at patients and see what happens. The dose of this protein required to reach the correct level in tumor cells may in fact push the level in normal cells to extremes. Killing 70% of a tumour is not good if it also causes 70% of your kidney to whither away and die.And delivary stratagies targeting specific cells have still not been well worked out.

  11. Re:This is quite a breakthrough... by dunedan · · Score: 3, Insightful

    while I agree with you that medical companies have probably gone a bit far with overcharging I really don't see why the medical industry should be that different from other industries.

    If they put billions into research and don't get paid for it then they won't do research.

    Think of it not as "poor people don't get this cause we patented it"

    instead think of it as "rich people pay exhorbitant amounts of money for new treatments so that eventually poor people can have them".

  12. Misleading headline by halothane · · Score: 4, Informative

    If you actually read the report, it says "70% of cancer cells", not "70% of cancers". Big difference.

  13. Re: UD.. - Not offtopic by drfrogsplat · · Score: 3, Informative
    The comment about UD packets isn't offtopic, for those who modded it such.

    The United Devices (UD) Cancer Research project allows people to crunch data (much like SETI@Home) but instead of finding alien life the idea is to find a cure for cancer. The software (as far as i can tell) models how various chemicals interact (IANAChemist, so I can't really give much more detail than that - check out the site if you're interested of course).

    Though this post to clarify the previous one may be getting offtopic :p

  14. I wonder... by Gamasta · · Score: 3, Interesting

    if cancers can evolve, eventually becoming immune to these proteins. I think not, but nature is often quite surprising.

    --
    reason defies logic
    1. Re:I wonder... by wilgamesh · · Score: 3, Interesting

      Very insightful. You would be describing the case of Gleevec, among I'm certain other cases. Gleevec is the wonder drug that's been shown to have great effects on leukemia (CML). However, patients will develop resistance to it during the course of treatment. The source of resistance, it turns out, is the mutation of the Gleevec target (a protein) such that it binds Gleevec differently.

      One story: http://www.researchmatters.harvard.edu/story.php?a rticle_id=510

      There's also the common idea that many cancers are multi-mutational events. That is, many mutations conspire in the cellular network to produce a cancerous cell. What that means is one cancer cell may have one method of producing all the right cell factors to proliferate wildly, while another cell employs a slightly different mechanism of doing so. This would mean that any single-prong approach to treating cancer would not be entirely successful. Hence, the article mentions that "multi-prong" approaches are a possible next step.